Does ENZALUTAMIDE Cause Hypersomnia? 231 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 231 reports of Hypersomnia have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.5% of all adverse event reports for ENZALUTAMIDE.
231
Reports of Hypersomnia with ENZALUTAMIDE
0.5%
of all ENZALUTAMIDE reports
26
Deaths
33
Hospitalizations
How Dangerous Is Hypersomnia From ENZALUTAMIDE?
Of the 231 reports, 26 (11.3%) resulted in death, 33 (14.3%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Hypersomnia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 231 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Hypersomnia?
PIMAVANSERIN (602)
ADALIMUMAB (467)
LENALIDOMIDE (401)
QUETIAPINE (394)
PREGABALIN (347)
TREPROSTINIL (317)
RISPERIDONE (302)
ARIPIPRAZOLE (286)
DULOXETINE (285)
OXYCODONE (280)
Which ENZALUTAMIDE Alternatives Have Lower Hypersomnia Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE